Migraine Medical Update - Nocira Gets Breakthrough Device Status
Episode 124: Lindsay Weitzel, PhD, and Timothy Smith, MD, discuss an up-and-coming migraine device being developed by a company called Nocira. The device is the first to be granted "Breakthrough Device" designation by the FDA for the treatment of acute migraine. This means that the FDA has determined that Nocira's clinical trial data has shown their device to be a more effective treatment than other currently available drugs or devices.
The National Headache Foundation first introduced you to this device in 2020 when Nocira's first round of very promising data was announced. Listen in to hear the awesome update on what this unique device that uses "Automated Variable Pulse Insufflation" into the ears, is doing for migraine patients in clinical trials.
Follow the National Headache Foundation's podcast HeadWise, as host Lindsay Weitzel, PhD, has informative discussions with headache experts on the latest treatment, research, lifestyle recommendations, and personal stories about living with migraine disease and headache disorders. HeadWise can be found on Apple Podcasts, Spotify, Stitcher, Overcast, or wherever you get your podcasts.
Subscribe for more episodes just like this: / nationalheadachefoundation
====================================================
Visit our website:
https://headaches.org/
====================================================
Follow us on social media:
Facebook: / nationalheadachefoundation
Instagram: / nationalheadachefoundation
Twitter: / nhf
====================================================
Download our podcast:
Apple Podcast: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/6Ip8umh...
#podcast #migraine #headache #healthcare #news #science #medicaldevices